Table of Contents
Afrezza is an inhaled insulin used to manage blood sugar levels in people with diabetes. However, because it involves inhaling medication directly into the lungs, individuals with asthma or other lung conditions need to exercise caution. Proper management ensures safety and effectiveness when using Afrezza.
Understanding the Risks
Afrezza delivers insulin through the lungs, which can potentially affect respiratory health. People with pre-existing lung conditions such as asthma, chronic obstructive pulmonary disease (COPD), or bronchitis may experience worsening symptoms or lung function issues. It is crucial to understand these risks before starting therapy.
Pre-Treatment Evaluation
Before using Afrezza, consult your healthcare provider for a comprehensive lung assessment. This may include:
- Reviewing your medical history
- Performing lung function tests such as spirometry
- Discussing any history of respiratory infections or symptoms
Monitoring While Using Afrezza
Regular monitoring is vital for individuals with lung conditions. Keep track of any changes in breathing, cough, or chest tightness. Report these symptoms promptly to your healthcare provider.
Signs to Watch For
Seek medical attention if you experience:
- Increased shortness of breath
- Wheezing or persistent cough
- Chest pain or tightness
- Frequent respiratory infections
Managing Lung Conditions During Treatment
Individuals with asthma or other lung conditions should continue their prescribed respiratory therapies. Using inhalers or other medications as directed can help maintain lung health while on Afrezza.
Additional Tips
- Inform your healthcare provider about all medications you are taking.
- Avoid exposure to respiratory irritants such as smoke or pollution.
- Maintain regular follow-up appointments for lung function testing.
- Have an asthma action plan in place for managing exacerbations.
Managing asthma or lung conditions when using Afrezza requires careful planning and communication with your healthcare team. With proper precautions, many individuals can safely benefit from this inhaled insulin therapy.